Status:
UNKNOWN
Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery
Lead Sponsor:
Indonesia University
Conditions:
Craniotomy Tumor Removal Surgery
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
This study aimed to compare continous intravenous lidocaine infusion and placebo on the effect to brain relaxation, opioid consumption and postoperative cognitive status in adult patient undergoing cr...
Detailed Description
Fifty subjects were given informed consent one day before surgery and then randomized into two groups: continous intravenous Lidocaine intraoperative and Placebo. Patient, the Anesthesist as data coll...
Eligibility Criteria
Inclusion
- Adult patient age 18-65 years old undergo craniotomy tumor removal surgery
- Physical status ASA 1-3
- Compos mentis (GCS 15)
- Operation using pin head fixation
Exclusion
- Patient or family refused to participate
- Has Atrioventricular block rhytm on ECG
- Has sign of circulation shock
- Midline shift \> 5.4 mm on brain imaging
- Diagnose with Glioblastoma multiforme or Metastatic
- Vascular surgery
- Using CSF drainage (EVD, VP shunt, or Lumbal drain)
- Routine using or in treatmet using adrenergic agonist or antagonist drugs
- Routine consumption of opioid in last two weeks before surgery
- History of Local anesthetic hypersensitivity
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04773093
Start Date
January 1 2021
End Date
December 31 2021
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National General Hospital Dr. Cipto Mangunkusumo
Jakarta Pusat, Indonesia, 10430